Cargando…

Comparable antiviral capacity but favorable in vitro survival of CD8s from elite controllers compared to untreated progressors

Detalles Bibliográficos
Autores principales:	Shasha, D, Porichis, F, Daniel, K, Angiuli, O, Kaufmann, DE, Walker, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441482/ http://dx.doi.org/10.1186/1742-4690-9-S2-P286

Ejemplares similares

0A07-01. HIV-specific CD8(+ )T-cells of vaccinees exhibit proliferative and cytotoxic capacities comparable to those of progressors
por: Rood, JE, et al.
Publicado: (2009)

Elite controllers long-term non progressors present improved survival and slower disease progression
por: Capa, Laura, et al.
Publicado: (2022)

Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors
por: Bronner, Mary P., et al.
Publicado: (2010)

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
por: Meijerink, Hinta, et al.
Publicado: (2014)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers
por: Descours, B, et al.
Publicado: (2009)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells
por: Kwaa, Abena K., et al.
Publicado: (2017)

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors
por: Díez-Fuertes, Francisco, et al.
Publicado: (2019)

Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers
por: Isnard, Stéphane, et al.
Publicado: (2022)

Comparative analysis of the impact of 40 adenovirus types on dendritic cell activation and CD8(+) T cell proliferation capacity for the identification of favorable immunization vector candidates
por: Wang, Xiaoyan, et al.
Publicado: (2023)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)

Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013)

An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers
por: Ding, Jiwei, et al.
Publicado: (2019)

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection
por: Ayala-Suárez, Rubén, et al.
Publicado: (2020)

Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors
por: Cellerai, Cristina, et al.
Publicado: (2011)

TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis
por: FRIIS-OTTESSEN, MARIANN, et al.
Publicado: (2015)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

P16-08. Combined blockade of the PD-1 and IL-10 pathways synergistically enhance HIV-specific CD4 T cell functions
por: Porichis, F, et al.
Publicado: (2009)

A high-dimensional immune monitoring model of HIV-1-specific CD8 T cell responses accurately identifies subjects achieving spontaneous viral control
por: Ndhlovu, ZM, et al.
Publicado: (2012)

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
por: Dam, Erik B, et al.
Publicado: (2009)

Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013)

Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers
por: Hokello, Joseph, et al.
Publicado: (2023)

Increased frequencies of CD8(+)CD57(+) T cells are associated with antibody neutralization breadth against HIV in viraemic controllers
por: Palmer, Christine D, et al.
Publicado: (2016)

Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+ and CD4+ T Cell Functionality
por: Chetty, Shivan, et al.
Publicado: (2015)

Comparing the effects of traditional resistance training and functional training on the bio-motor capacities of female elite taekwondo athletes
por: Khazaei, Leila, et al.
Publicado: (2023)

The CD8(+) T Cell Noncytotoxic Antiviral Responses
por: Morvan, Maelig G., et al.
Publicado: (2021)

Elevated Expression of miR-19b Enhances CD8(+) T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral Suppression
por: Yin, Lin-Bo, et al.
Publicado: (2019)

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
por: Zhang, Ming, et al.
Publicado: (2018)

Suppression of HIV Replication by CD8(+) Regulatory T-Cells in Elite Controllers
por: Lu, Wei, et al.
Publicado: (2016)

A soluble activator that favors the ex vivo expansion of CD8(+)CD27(+) T cells
por: Matus, Esther I., et al.
Publicado: (2020)

Preferential targeting of co-evolving Gag residues in long-term non progressors
por: Sunshine, J, et al.
Publicado: (2012)

Unexpected Response to Nivolumab in a “Fast Progressor” Head and Neck Cancer Patient
por: Napolitano, Martina, et al.
Publicado: (2019)

Comparative values of several tumour markers: example of untreated breast carcinoma.
por: Cazin, J. L., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_m2rg4i6go5o9gfspeuccffnttc